Saralegui Borja Cembrero - 04 Jun 2025 Form 4 Insider Report for My Size, Inc. (MYSZ)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
06 Jun 2025, 16:10:18 UTC
Prior SEC filing
28 May 2025
Next SEC filing
17 Dec 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Borja Cembrero

Key filing fact

Saralegui Borja Cembrero filed Form 4 for My Size, Inc. (MYSZ) on 06 Jun 2025.

Key facts

  • This page summarizes Saralegui Borja Cembrero's Form 4 filing for My Size, Inc. (MYSZ).
  • 4 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 06 Jun 2025, 16:10.

Change

  • Previous filing in this sequence was filed on 28 May 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002067690 Primary reporting owner

Cembrero Saralegui Borja

Relationship
Chief Growth Officer
Address
C/O MY SIZE INC., HANEGEV 4, POB 1026, AIRPORT CITY, ISRAEL
Signature
/s/ Borja Cembrero
Signature date
06 Jun 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MYSZ transaction Derivative

Option to purchase Common Stock (right to buy)

Disposed to Issuer

Transaction value
Shares
-1,688
Change %
-100%
Price
Shares after
0
Date
04 Jun 2025
Ownership
Direct
Underlying class
Common Stock, $.001 par value per share
Underlying amount
1,688
Exercise price
$8.72
Footnotes
F1, F3
MYSZ transaction Derivative

Option to purchase Common Stock (right to buy)

Award

Transaction value
Shares
+1,688
Change %
Price
Shares after
1,688
Date
04 Jun 2025
Ownership
Direct
Underlying class
Common Stock, $.001 par value per share
Underlying amount
1,688
Exercise price
$1.28
Footnotes
F1, F3
MYSZ transaction Derivative

Option to purchase Common Stock (right to buy)

Disposed to Issuer

Transaction value
Shares
-2,500
Change %
-100%
Price
Shares after
0
Date
04 Jun 2025
Ownership
Direct
Underlying class
Common Stock, $.001 par value per share
Underlying amount
2,500
Exercise price
$3.83
Footnotes
F2, F3
MYSZ transaction Derivative

Option to purchase Common Stock (right to buy)

Award

Transaction value
Shares
+2,500
Change %
Price
Shares after
2,500
Date
04 Jun 2025
Ownership
Direct
Underlying class
Common Stock, $.001 par value per share
Underlying amount
2,500
Exercise price
$1.28
Footnotes
F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The options were granted under the My Size, Inc. 2017 Equity Incentive Plan and vest and become exercisable in three equal installments, with 1/3 vesting on each of July 13, 2024, July 13, 2025 and July 13, 2026, subject to the Reporting Person's continued service.

Footnote F2

The options were granted under the My Size, Inc. 2017 Equity Incentive Plan and vest and become exercisable in three equal installments, with 1/3 vesting on each of February 14, 2025, February 14, 2026 and February 14, 2027, subject to the Reporting Person's continued service.

Footnote F3

Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

SEC remarks

On April 23, 2024, the Company implemented a 1-for-8 reverse stock split (the "Reverse Stock Split") of the Company's common stock. All amounts have been adjusted to give effect to the Reverse Stock Split.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .